[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice-Reference-Cited by-同舟云学术

[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice

Published:2021-01-04 Issue:6 Volume:48 Page:1773-1784
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Van Simaeys Gaetan^ORCID,Doumont Gilles,De Maeseneire Coraline,Passon Nicolas,Lacroix Simon,Lentz Cédric,Horion Arnaud,Warnier Corentin,Torres David,Martens Corentin,Vierasu Irina,Egrise Dominique,Goldman Serge^ORCID

Funder

Walloon Region

ERDF

Fondation ULB

Fonds Erasme

Association Vinçotte Nuclear

Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-020-05169-z.pdf

Reference41 articles.

1. Mottet N, van den Bergh RCN, Briers E, Cornford P, De Santis M, Fanti S, et al. EAU guidelines: prostate cancer. 2019. Uroweb. https://uroweb.org/guideline/prostate-cancer/.

2. Cornford P, Bellmunt J, Bolla M, Briers E, Santis MD, Gross T, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: Treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. Elsevier; 2017;71:630–42. https://www.europeanurology.com/article/S0302-2838(16)30469-9/abstract.

3. Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019;46:2536–44. https://doi.org/10.1007/s00259-019-04485-3.

4. Wright GL, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, et al. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology. 1996;48:326–34.

5. Meller B, Bremmer F, Sahlmann CO, Hijazi S, Bouter C, Trojan L, et al. Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy. EJNMMI Res. 2015;5.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Imaging of Prostate Cancer;Seminars in Nuclear Medicine;2023-09

2. Determination lipid peroxidation (MDA) and catalase levels with prostate specific antigen (PSA) level in Iraqi patients suffering from prostate cancer;Egyptian Journal of Chemistry;2022-05-17

3. Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management;Cancers;2022-04-14

4. Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT;European Journal of Hybrid Imaging;2022-03-15